ASTH — APOLLO MED HLDGS INC

Ownership history in XTX Topco Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in APOLLO MED HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2023 Q1)
Avg. % of fund
0.06%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 9,513 -8,675 -47.7% 0.01% $270K $28.35
2025 Q1 ADDED 18,188 +3,824 +26.6% 0.03% $564K $31.01
2024 Q1 REDUCED 14,364 -615 -4.1% 0.08% $603K $41.99
2023 Q1 ADDED 14,979 +7,079 +89.6% 0.11% $546K $36.47
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ASTH price (monthly, adj. close)

Other funds also holding ASTH

As of 2025 Q4 — sorted by position size

325 CAPITAL LLC 3Y 15.99% 1492 Capital Management LLC 3Y 7Y 1.59% QSV Equity Investors LLC 1.09% SteelPeak Wealth, LLC 3Y 0.47% Insight Wealth Strategies, LLC 3Y 7Y 0.4% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.38% Shay Capital LLC 3Y 0.31% Capstone Capital Management Ltd 0.28% NorthCrest Asset Manangement, LLC 3Y 0.28% ROYCE & ASSOCIATES LP 3Y 7Y 0.09%
← Back to XTX Topco Ltd Holdings